Aztiq Pharma Partners S.a r.l. - 17 Dec 2025 SCHEDULE 13D/A Report for Alvotech Ordinary Shares, nominal value of $0.01 per share (ALVO)

Filing Manager
Aztiq Pharma Partners S.a r.l.
Reporting Manager
Aztiq Pharma Partners S.a r.l.
Security
Alvotech Ordinary Shares, nominal value of $0.01 per share
Symbol
ALVO
Shares outstanding
311,860,120 shares
Disclosed Ownership
103,849,420 shares
Ownership
33%
Form type
SCHEDULE 13D/A
Filing time
12 Mar 2026, 16:09:00 UTC
Date of event
17 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Aztiq Pharma Partners S.a r.l. disclosed 33% ownership in Alvotech Ordinary Shares, nominal value of $0.01 per share (ALVO) on 17 Dec 2025."

Quick Takeaways

  • Aztiq Pharma Partners S.a r.l. filed SCHEDULE 13D/A for Alvotech Ordinary Shares, nominal value of $0.01 per share (ALVO).
  • Disclosed ownership: 33%.
  • Date of event: 17 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Mar 2026, 16:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Aztiq Pharma Partners S.a r.l. 33% 103,849,420 0 103,849,420 /s/ David Olafsson By David Olafsson, Manager 0001936288
Aztiq Fund I SCSp 33% 103,849,420 0 103,849,420 /s/ David Olafsson By Floki GP S.a r.l., its general partner, By David Olafsson, Manager
Floki GP S.a r.l. 33% 103,849,420 0 103,849,420 /s/ David Olafsson By David Olafsson, Manager
ATP ehf. 1% 3,003,290 0 3,003,290 /s/ David Olafsson By David Olafsson, Director
ATP Holdings ehf. 1% 3,020,861 17,571 3,003,290 /s/ David Olafsson By David Olafsson, Director

Sponsored